Novel Anilinophthalimide Derivatives As Potential Probes for Beta-Amyloid Plaque in the Brain

Xin-Hong Duan,Jin-Ping Qiao,Yang,Meng-Chao Cui,Jiang-Ning Zhou,Bo-Li Liu
DOI: https://doi.org/10.1016/j.bmc.2009.12.023
IF: 3.461
2010-01-01
Bioorganic & Medicinal Chemistry
Abstract:A group of novel 4,5-dianilinophthalimide derivatives has been synthesized in this study for potential use as beta-amyloid (A beta) plaque probes. Staining of hippocampus tissue sections from Alzheimer's disease (AD) brain with the representative compound 9 indicated selective labeling of it to A beta plaques. The binding affinity of radioiodinated [I-125]9 for AD brain homogenates was 0.21 nM (K-d), and of other derivatives ranged from 0.9 to 19.7 nM, except for N-methyl-4,5-dianilinophthalimide (K-i > 1000 nM). [I-125]9 possessed the optimal lipophilicity with Log P value of 2.16, and its in vivo biodistribution in normal mice exhibited excellent initial brain uptake (5.16% ID/g at 2 min after injection) and a fast washout rate (0.56% ID/g at 60 min). The encouraging results suggest that this novel derivative of [I-123]9 may have potential as an in vivo SPECT probe for detecting amyloid plaques in the brain. (C) 2009 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?